Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Chinook Therapeutics Q1 Earnings

Chinook Therapeutics (NASDAQ:KDNY) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:00 PM. Here’s what…
byBenzinga Insights
May 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Chinook Therapeutics (NASDAQ:KDNY) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Chinook Therapeutics missed estimated earnings by 7.59%, reporting an EPS of $-0.85 versus an estimate of $-0.79.

Revenue was down $869 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 1.16% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Chinook Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Why Cosmetics Major Estee Lauder Shares Are Rocketing Premarket Monday

By Lekha Gupta
February 5, 9:56 AM
Estee Lauder (EL) shares surge premarket as Q2 FY24 results surpass expectations. Despite a 7% sales decline, solid earnings and a quarterly dividend of $0.66 per share signal resilience. The company revised FY24 outlook, announcing a Profit Recovery Plan for FY25-FY26, projecting substantial benefits and a focus on consumer-facing activities.

EL